-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Iovance Biotherapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from Q2 2022 to Q2 2024.
- Iovance Biotherapeutics, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $133M, a 20.6% increase year-over-year.
- Iovance Biotherapeutics, Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $492M.
- Iovance Biotherapeutics, Inc. annual Costs and Expenses for 2023 was $462M, a 15.8% increase from 2022.
- Iovance Biotherapeutics, Inc. annual Costs and Expenses for 2022 was $399M, a 16.4% increase from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)